What is the Impact Factor of Oncologie?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Oncologie is 2.10, ranking in quartile Q3 of Web of Science (SCIE).

Is Oncologie indexed in Web of Science or Scopus?

Yes, Oncologie is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.391 (Q3) and an H-index of 15.

Who publishes Oncologie and what is the Article Processing Charge (APC)?

Oncologie is published by Tech Science Press. The estimated Article Processing Charge (APC) is approximately $2,594 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Oncologie?

The official ISO-4 abbreviation of Oncologie is "ONCOLOGIE". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q3SCImago #14,437Hybrid

Oncologie

Abbreviation (ISO):ONCOLOGIE

•

Identifier (ISSN):1292-3818(Print)/1765-2839(Online)

•

Publisher:Tech Science Press

Official Website Submission Portal Compare

Clarivate IF (2026)

2.1↓ -0.4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Oncologie

WoS Q3

Annual Impact Factor Metric

Current (2026):2.1

Scopus SJR & RankScopus Q3

0.391

#14,437

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

15 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate7.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

44articles/year

99.59% Gold OA•70% Original Research

Aims & Scope

Oncologie is aimed to the publication of high quality original research articles, review papers, case report, etc. with an active interest in vivo or vitro study of cancer biology. Study relating to the pathology, diagnosis, and advanced treatment of all types of cancers, as well as research from any of the disciplines related to this field of interest. The journal has English and French bilingual publication.

Topics Covered (Recognized by AI)

MedicineBiologyInternal MedicineGeneticsPhilosophy

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank236/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank253/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	236/333	Q3
ONCOLOGY	JCISCIE	253/333	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.1

Articles / Year40

Total Citations1

2025

IF2.5

Articles / Year98

Total Citations60

2024

IF1.4

Articles / Year94

Total Citations323

2023

IF0.9

Articles / Year88

Total Citations319

2022

IF0.9

Articles / Year61

Total Citations596

Year	Impact Factor	Articles / Year	Total Citations
2026	2.1	40	1
2025	2.5	98	60
2024	1.4	94	323
2023	0.9	88	319
2022	0.9	61	596
2021	0.333	47	233
2020	0.052	32	136
2019	0.043	14	5
2018	0.035	26	17
2017	—	63	66
2016	—	100	121
2015	—	86	55

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #14,437Scopus Q3SCImago Profile

Scopus Coverage:1999-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q3

0.391

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.97

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,594 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations419

3-Year Documents212

Citable Documents209

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 7.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Oncologie (abbr: ONCOLOGIE, ISSN: 1292-3818) is a peer-reviewed international scholarly journal in the field of Medicine, published by Tech Science Press in France since 2004. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.391 (Q3), an H-index of 15.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 44 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,594 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.